Clinical trial
Atenativ Effect on Uterine Blood Flow and Preeclampsia
NCT02278575
Study timeline
Study start (unknown)2016-01-01Date precision: month
Registry last updated2017-09-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Antithrombin III Deficiencyunresolved
Interventions
AtenativDRUG
Sponsors & collaborators
Vastra Gotaland Regionlead sponsor
Octapharmacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02278575 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.